The latest market report published by Acute Market Reports “Preventive Healthcare Technologies, Products And Services Market - Growth, Future Prospects, Competitive Analysis, 2021 - 2029,” the global preventive healthcare technologies, products and services market was valued at US$ 177.2 Bn in 2020, and is expected to reach US$ 487.4 Bn by 2025 expanding at a CAGR of 10.99 % from 2021 to 2029.
Browse the full report Preventive Healthcare Technologies, Products And Services Market - Growth, Future Prospects, Competitive Analysis, 2021 – 2029 report at https://www.acutemarketreports.com/report/preventive-healthcare-technologies-products-and-services-market
Market Insights
Prophylaxis and vaccination are the best medical treatment protocols that are used for the prevention of grave diseases such as meningitis, polio, tuberculosis and diphtheria, measles. The criteria which are taken in consideration for the determination of vaccines market are the disease etiology, drug pipeline, the pricing strategies and governments’ role in purchasing from the manufacturers and dispensing them to the people under health welfare schemes etc. are having a positive influence on the market growth for the preventive healthcare technologies, products and services.
As of now, early detection and screening technologies hold the largest market share due to key drivers such as increase in the number of drug molecules clearing the preclinical studies and requirement of early screening of drug pharmacokinetics and pharmacodynamics, and the increasing demand for personalized medication. Advanced technologies to reduce errors segment shows a promising sales forecast and is anticipated be the fastest growing market chiefly due to drivers such as burgeoning requirement for safe drug packaging to maintain product quality and eminent requirement of automated prescription formulation to meet drug dosage requirement of patients in remote areas.
In the current scenario, North America dominates the regional markets and the growth of this region is mainly attributed to the presence of key drivers such as rising prevalence of health complications, existence of developed healthcare facilities and presence of major players engaged in the manufacture and sale of preventive healthcare technologies, products and services. Asia Pacific promises lucrative market opportunities with encouraging sales forecast chiefly due to factors such as rising morbidity due to tropical diseases and existence of counterfeit market resulting in increased reporting of adverse events.
The preventive healthcare technologies, products and services market is technologically driven and includes major players such as Alere, Inc., GlaxoSmithKline Plc, Healthways, Inc., McKesson Corporation, Medtronic Plc, Merck & Co. Inc., Pfizer, Inc., Omnicell, Inc. and Scripto LLC.
Key Market Movements:
